Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
D000243:Adenosine Deaminase / Q000172:deficiency*; D000284:Administration, Oral; D002648:Child; D003564:Cytidine Deaminase; D003841:Deoxycytidine / Q000008:administration & dosage*; D004176:Dipyridamole / Q000008:administration & dosage*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000276:immunology; D007263:Infusions, Parenteral; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors / Q000172:deficiency*; D013997:Time Factors
D003841:Deoxycytidine; D004176:Dipyridamole; D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase; D003564:Cytidine Deaminase; C011530:deoxycytidine deaminase